Skip to main content
. 2015 May 27;6:483. doi: 10.3389/fmicb.2015.00483

Figure 4.

Figure 4

Species distribution of characterized isolates from (A) BEA (bile esculin azide agar), (B) BEAE (bile esculin azide agar amended with erythromycin [8 μg/mL]) and (C) BEAT (bile esculin azide agar amended with tylosin [32 μg/mL]). Prevalence was calculated by dividing the number of isolates for each species by the total number of isolates from each sample day and treatment.